Development of B cells, white blood cells that make antibodies, follows a progression of stages: common lymphoid progenitors, ...

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipelineDren Bio deep B-cell ...

Sanofi has announced that it will be broadening its immunology pipeline by acquiring Dren Bio’s phase 1 CD20-directed ...

There are two forms: Partial remission. Your B-cell lymphoma has gotten smaller, but it's still there. Usually the cancer has shrunk by half or more. Complete remission. Your doctor can't find any ...

Germinal centers are high-speed evolution machines. Tiny clusters in the lymph nodes, germinal centers refine antibodies ...

Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has agreed to acquire DR-0201, a targeted bispecific myeloid ...